Journal Home
Search for

Volume 65, Issue 2, Pages 175-182 (August 2004)


View previous. 7 of 15 View next.

Intermittent and recurrent hepatomegaly due to glycogen storage in a patient with type 1 diabetes: Genetic analysis of the liver glycogen phosphorylase gene (PYGL)

Masako Tomihiraa, Eiji Kawasakib, Hiromu Nakajimac, Yutaka Imamurad, Yuichi Satoa, Michio Satae, Masayoshi Kagef, Hideo Sugieg, Kiyohide NunoiaCorresponding Author Informationemail address

Received in revised form 12 February 2003; accepted 12 December 2003.

Abstract 

We report a 19-year-old woman who had a history of type 1 diabetes with recurrent glycogen accumulation in the liver. During her infantile period she presented with no hepatomegaly nor growth retardation. On admission she was diagnosed with diabetic ketoacidosis (DKA). She also had hepatomegaly and elevated transaminase levels, but these abnormalities had resolved after administration of insulin. However, 4 weeks after DKA marked hepatomegaly and elevated transaminases were reappeared with simultaneous hypoglycemia which suggested an impaired glycogenolysis in the extraordinary conditions. We supposed the partial deficiency of liver glycogen phosphorylase activity in this patient and analyzed the liver glycogen phosphorylase gene (PYGL). Deduced amino acid sequence of the PYGL in this patient was completely identical to that reported by Burwinkel et al. (Y15233), however, the nucleotide sequence of PYGL cDNA was heterozygous for substitutions at positions Asp339 ( to ) on exon 9 and Ala703 ( to on exon 17, respectively. These SNPs were also screened in 51 Japanese normal subjects by PCR-based direct sequencing or PCR–RFLP method. The same genotype observed in this patient was detected in 2 of 51(3.9%) normal subjects. These results suggest that the structure of PYGL coding sequence in this patient is unlikely to account for her excessive liver glycogen accumulation. Further studies including genetic analysis on the promoter region of the gene are necessary to clarify the etiology of susceptibility to excessive liver glycogen storage in patients with type 1 diabetes.

a Division of Endocrinology and Metabolism, St. Mary’s Hospital, 422 Tsubukuhonmachi, Kurume, Fukuoka, Japan

b Unit of Metabolism/Diabetes and Clinical Nutrition, Nagasaki University School of Medicine, Nagasaki, Japan

c Department of Clinical Laboratory, Osaka Medical Center for Cancer and Cardiovascular Diseases (OMCC), Osaka, Japan

d Division of Hematology, St. Mary’s Hospital, 422 Tsubukuhonmachi, Kurume, Fukuoka, Japan

e Second Department of Internal Medicine, Kurume University of School of Medicine, Fukuoka, Japan

f First Department of Pathology, Kurume University of School of Medicine, Fukuoka, Japan

g Department of Pediatric Neurology, Hamamatsu City Medical Center for Developmental Medicine, Shizuoka, Japan

Corresponding Author InformationCorresponding author. Tel.: +81-942-35-3322; fax: +81-942-34-3575.

PII: S0168-8227(03)00335-8

doi:10.1016/j.diabres.2003.12.004


View previous. 7 of 15 View next.